Herpes Simplex Virus (HSV) Treatment Market to Grow at 8.05% through 2030F

Increasing prevalence of HSV infection is expected to drive the growth of Global Herpes Simplex Virus (HSV) Treatment Market in the forecast period, 2026-2030.

According to TechSci Research report, “Herpes Simplex Virus (HSV) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F,” Global Herpes Simplex Virus (HSV) Treatment Market was valued at USD 2.52 billion in 2024 and is expected to reach USD 3.98 billion by 2030 with a CAGR of 8.05% during the forecast period. This can be ascribed to the increase in infectious disease outbreaks along with rising cases of hospital-acquired infection among the population across the globe. The growing demand for acyclovir across the globe and increasing demand for effective treatment for rare diseases, especially in the developed countries in North America and Europe, is expected to create lucrative opportunities for market growth in coming years. Besides, increasing transmission of herpes and a surge in the usage of unhygienic practices in underdeveloped and developing countries is further expected to support the market growth.

However, side effects related to the use of drugs and ignorance of treatment for herpes are likely to slow down the growth of the Global Herpes Simplex Virus (HSV) Treatment Market in the forecast period. Similarly, the lack of reimbursement procedures for HSV treatment and the high cost of treatment may hamper the Herpes Simplex Virus (HSV) Treatment market growth during the forecast period. Also, a lack of awareness about the new therapy for the treatment in emerging countries can further restrict the growth of the Global Herpes Simplex Virus (HSV) Treatment Market.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Herpes Simplex Virus (HSV) Treatment Market"

The Global Herpes Simplex Virus (HSV) Treatment Market can be segmented by virus type, by treatment, by route of administration, by distribution channel, and by region.

Based on treatment, Drugs is the Fastest Growing Segment over vaccines in the Global Herpes Simplex Virus (HSV) Treatment Market. This dominance stems from the fact that there is no approved HSV vaccine available for widespread use yet, despite ongoing research and clinical trials. Antiviral drugs like acyclovir, valacyclovir, and famciclovir remain the primary method for managing HSV infections by reducing symptoms, outbreak frequency, and transmission risk. Vaccines, while highly desirable for prevention, face scientific challenges due to the virus’s ability to establish lifelong latency and evade the immune system. These complexities have delayed the development and approval of effective vaccines. Until a safe and effective vaccine becomes available, patients and healthcare providers rely on antiviral drugs for treatment. The dominance of drugs reflects the current unmet need for symptom management and outbreak control, driving steady market demand. Once vaccines are successfully developed and approved, they may reshape the market by focusing on prevention rather than treatment, but for now, drugs remain the cornerstone of HSV management.

Major companies operating in Global Herpes Simplex Virus (HSV) Treatment Market are:

·         Novartis International AG

·         GlaxoSmithKline, plc.

·         Sanofi SA

·         Mylan N.V.

·         Emcure Pharmaceuticals Ltd.

·         Glenmark Pharmaceuticals Inc.

·         Fresenius Kabi AG

·         Apotex Inc.

·         Viatris Inc.

·         Teva Pharmaceuticals Industries Ltd

 
Download Free Sample Report

Customers can also request for 10% free customization on this report.

“North America was expected to dominate in the Global Herpes Simplex Virus (HSV) Treatment Market on account due to the increasing demand for branded herpes drugs along with the increasing launch of generics across the region. Furthermore, increasing development of healthcare expenditure and growing favorable reimbursement policies for HSV treatment are further contributing to the demand for herpes simplex virus treatment. Besides, the availability of skilled professionals and early adoption of advanced treatments for herpes treatment in the region is further expected to create lucrative opportunities for market growth,” said Mr. Karan Chechi, Research Director of TechSci Research, a research based global management consulting firm.

“Herpes Simplex Virus (HSV) Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Virus Type (HSV-1 v/s HSV-2), By Treatment (Drugs v/s Vaccines), By Route of Administration (Oral, Intravenous, Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region & Competition 2020-2030F” has evaluated the future growth potential of Global Herpes Simplex Virus (HSV) Treatment Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Herpes Simplex Virus (HSV) Treatment Market.

 
Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com